Lilly's $3.8 Billion Vaccine Bets: A Quiet Shift Now
Lilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
Stock picking requires research and discipline; assess whether your time, resources, and goals justify active selection over passive options.
17,093 articlesLilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
Adobe prepares to report Q2 results after the bell as investors scrutinize AI-driven growth, ARR expansion, and capit...
SpaceX’s sharp stock surge lifts market mood as oil prices slip, pushing the Nasdaq toward fresh highs. Analysts say ...
Costco reports solid membership-driven results in mid-2026, but the stock faces a high bar for growth and valuation. ...
Snap aims to redefine how we interact with the world through AR glasses, but can this gadget lift the stock? This gui...
JPMorgan Chase just paired a 10% dividend hike with a $50 billion buyback after clearing the Fed's stress test. Here'...
Netflix trades near its 52-week low as operating strength clashes with subscriber-growth concerns. A stronger FY26 ca...
Bloom Energy skyrocketed over 248% in the first half of 2026, delivering eye-popping gains for early investors. This ...
Seagate Technology’s blistering rally shows no signs of slowing as AI storage demand sustains gains. With bulls eyein...
When a chief executive sells stock, investors ask if the move is a red flag or a routine tax-related step. This piece...
As tesla heads into july, the market faces a tug-of-war: robust quarterly deliveries versus pressure on margins and a...
Microsoft sits near a long-running price anchor as investors weigh AI incentives against macro risks. A decisive move...